Open Access Helper

OpenAlex Citation Counts

OpenAlex Citations Logo

OpenAlex is a bibliographic catalogue of scientific papers, authors and institutions accessible in open access mode, named after the Library of Alexandria. It's citation coverage is excellent and I hope you will find utility in this listing of citing articles!

If you click the article title, you'll navigate to the article, as listed in CrossRef. If you click the Open Access links, you'll navigate to the "best Open Access location". Clicking the citation count will open this listing for that article. Lastly at the bottom of the page, you'll find basic pagination options.

Requested Article:

Risk of Breakthrough SARS-CoV-2 Infections in Adult Transplant Recipients
Caroline X. Qin, Linda W. Moore, Shweta Anjan, et al.
Transplantation (2021) Vol. 105, Iss. 11, pp. e265-e266
Open Access | Times Cited: 155

Showing 1-25 of 155 citing articles:

Emerging COVID-19 variants and their impact on SARS-CoV-2 diagnosis, therapeutics and vaccines
Queenie Fernandes, Varghese Inchakalody, Maysaloun Merhi, et al.
Annals of Medicine (2022) Vol. 54, Iss. 1, pp. 524-540
Open Access | Times Cited: 372
Cellular immunity predominates over humoral immunity after homologous and heterologous mRNA and vector-based COVID-19 vaccine regimens in solid organ transplant recipients
Tina Schmidt, Verena Klemis, David Schub, et al.
American Journal of Transplantation (2021) Vol. 21, Iss. 12, pp. 3990-4002
Open Access | Times Cited: 142
SARS-CoV2-specific Humoral and T-cell Immune Response After Second Vaccination in Liver Cirrhosis and Transplant Patients
Darius F. Ruether, Golda Schaub, Paul Duengelhoef, et al.
Clinical Gastroenterology and Hepatology (2021) Vol. 20, Iss. 1, pp. 162-172.e9
Open Access | Times Cited: 133
Immunogenicity and Risk Factors Associated With Poor Humoral Immune Response of SARS-CoV-2 Vaccines in Recipients of Solid Organ Transplant
Kasama Manothummetha, Nipat Chuleerarux, Anawin Sanguankeo, et al.
JAMA Network Open (2022) Vol. 5, Iss. 4, pp. e226822-e226822
Open Access | Times Cited: 87
Vaccination in patients with kidney failure: lessons from COVID-19
Nina Babel, Christian Hugo, Timm H. Westhoff
Nature Reviews Nephrology (2022) Vol. 18, Iss. 11, pp. 708-723
Open Access | Times Cited: 79
The Global Impact of COVID-19 on Solid Organ Transplantation: Two Years Into a Pandemic
Ailish Nimmo, Dale Gardiner, Ines Ushiro‐Lumb, et al.
Transplantation (2022) Vol. 106, Iss. 7, pp. 1312-1329
Open Access | Times Cited: 76
Serological Response to Three, Four and Five Doses of SARS-CoV-2 Vaccine in Kidney Transplant Recipients
Bilgin Osmanodja, Simon Ronicke, Klemens Budde, et al.
Journal of Clinical Medicine (2022) Vol. 11, Iss. 9, pp. 2565-2565
Open Access | Times Cited: 76
A third dose of SARS-CoV-2 vaccine increases neutralizing antibodies against variants of concern in solid organ transplant recipients
Andrew H. Karaba, Xianming Zhu, Tao Liang, et al.
American Journal of Transplantation (2021) Vol. 22, Iss. 4, pp. 1253-1260
Open Access | Times Cited: 98
Weak antibody response to three doses of mRNA vaccine in kidney transplant recipients treated with belatacept
Nathalie Chavarot, Antoine Morel, Marianne Leruez‐Ville, et al.
American Journal of Transplantation (2021) Vol. 21, Iss. 12, pp. 4043-4051
Open Access | Times Cited: 93
Antibody Response to a Fourth Dose of a SARS-CoV-2 Vaccine in Solid Organ Transplant Recipients: A Case Series
Jennifer L. Alejo, Jonathan Mitchell, Teresa Po‐Yu Chiang, et al.
Transplantation (2021) Vol. 105, Iss. 12, pp. e280-e281
Open Access | Times Cited: 66
COVID-19 and kidney disease: insights from epidemiology to inform clinical practice
Viyaasan Mahalingasivam, Guobin Su, Masao Iwagami, et al.
Nature Reviews Nephrology (2022) Vol. 18, Iss. 8, pp. 485-498
Open Access | Times Cited: 65
Impact of Vaccination and Early Monoclonal Antibody Therapy on Coronavirus Disease 2019 Outcomes in Organ Transplant Recipients During the Omicron Wave
Javier T Solera, Berta G. Árbol, Abdullah M. Al-Shahrani, et al.
Clinical Infectious Diseases (2022) Vol. 75, Iss. 12, pp. 2193-2200
Open Access | Times Cited: 56
Neutralizing antibody response against the B.1.617.2 (delta) and the B.1.1.529 (omicron) variants after a third mRNA SARS-CoV-2 vaccine dose in kidney transplant recipients
Louise Benning, Christian Morath, Marie Bartenschlager, et al.
American Journal of Transplantation (2022) Vol. 22, Iss. 7, pp. 1873-1883
Open Access | Times Cited: 46
Heart transplantation: focus on donor recovery strategies, left ventricular assist devices, and novel therapies
María G. Crespo‐Leiro, Maria Rosa Costanzo, Finn Gustafsson, et al.
European Heart Journal (2022) Vol. 43, Iss. 23, pp. 2237-2246
Open Access | Times Cited: 39
Humoral and cellular immune correlates of protection against COVID-19 in kidney transplant recipients
Delphine Kemlin, Nicolas Gemander, Stéphanie Depickère, et al.
American Journal of Transplantation (2023) Vol. 23, Iss. 5, pp. 649-658
Open Access | Times Cited: 24
Excess mortality in COVID-19-affected solid organ transplant recipients across the pandemic
Shigeyoshi Yamanaga, Keita Shimata, Satoko Ohfuji, et al.
American Journal of Transplantation (2024) Vol. 24, Iss. 8, pp. 1495-1508
Open Access | Times Cited: 7
Neutralization of SARS-CoV-2 Variants in Transplant Recipients After Two and Three Doses of mRNA-1273 Vaccine
Deepali Kumar, Victor H. Ferreira, Victoria Hall, et al.
Annals of Internal Medicine (2021) Vol. 175, Iss. 2, pp. 226-233
Open Access | Times Cited: 48
SARS‐CoV‐2 Infections Among Patients With Liver Disease and Liver Transplantation Who Received COVID‐19 Vaccination
Andrew M. Moon, Gwilym J. Webb, Ignacio García‐Juárez, et al.
Hepatology Communications (2021) Vol. 6, Iss. 4, pp. 889-897
Open Access | Times Cited: 44
Antibody Responses after a Third Dose of COVID-19 Vaccine in Kidney Transplant Recipients and Patients Treated for Chronic Lymphocytic Leukemia
Julien Marlet, Philippe Gatault, Zoha Maakaroun, et al.
Vaccines (2021) Vol. 9, Iss. 10, pp. 1055-1055
Open Access | Times Cited: 43
Quantifying excess deaths among solid organ transplant recipients in the COVID-19 era
Allan B. Massie, William A. Werbel, Robin K. Avery, et al.
American Journal of Transplantation (2022) Vol. 22, Iss. 8, pp. 2077-2082
Open Access | Times Cited: 36
The risk and consequences of breakthrough SARS-CoV-2 infection in solid organ transplant recipients relative to non-immunosuppressed controls
Amanda J. Vinson, Alfred Anzalone, Jing Sun, et al.
American Journal of Transplantation (2022) Vol. 22, Iss. 10, pp. 2418-2432
Open Access | Times Cited: 31
Update on COVID-19 Therapeutics for Solid Organ Transplant Recipients, Including the Omicron Surge
Robin K. Avery
Transplantation (2022) Vol. 106, Iss. 8, pp. 1528-1537
Open Access | Times Cited: 29
Perspective on COVID-19 vaccination in patients with immune-mediated kidney diseases: consensus statements from the ERA-IWG and EUVAS
Kate Stevens, Eleni Frangou, Jae Il Shin, et al.
Nephrology Dialysis Transplantation (2022) Vol. 37, Iss. 8, pp. 1400-1410
Open Access | Times Cited: 28
A fourth SARS-CoV-2 mRNA vaccine in strictly seronegative kidney transplant recipients
Christophe Masset, Jacques Dantal, Diego Cantarovich, et al.
Kidney International (2022) Vol. 101, Iss. 4, pp. 825-826
Open Access | Times Cited: 27
Outcomes of SARS-CoV-2 Infection in Unvaccinated Compared With Vaccinated Solid Organ Transplant Recipients: A Propensity Matched Cohort Study
Victoria Hall, Ghadeer Al-Alahmadi, Javier T Solera, et al.
Transplantation (2022) Vol. 106, Iss. 8, pp. 1622-1628
Open Access | Times Cited: 27
Page 1 - Next Page

Scroll to top